Differentiating combined hepatocellular and cholangiocarcinoma from mass-forming intrahepatic cholangiocarcinoma using gadoxetic acid-enhanced MRI

Journal of Magnetic Resonance Imaging

Volumn 36, Issue 4, 2012, Pages 881-889

  Hwang, Jiyoung ^a,b   Kim, Young Kon ^a   Park, Min Jung ^a   Lee, Mi Hee ^a   Kim, Seong Hyun ^a   Lee, Won Jae ^a   Rhim, Hyun Chul ^a  

^a Sungkyunkwan University   (South Korea)

^b Soonchunhyang University   (South Korea)

Author keywords

combined hepatocellular and cholangiocarcinoma; Gd EOB DTPA; intrahepatic cholangiocarcinoma; liver; MRI

Indexed keywords

GADOXETIC ACID;

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; CANCER SIZE; CANCER SURGERY; CLINICAL ARTICLE; COMBINED HEPATOCELLULAR CHOLANGIOCARCINOMA; CONTRAST ENHANCEMENT; FEMALE; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER RESECTION; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

ADULT; AGED; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CARCINOMA, HEPATOCELLULAR; CHOLANGIOCARCINOMA; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; FEMALE; GADOLINIUM DTPA; HUMANS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84866406313     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.23728     Document Type: Article

References (28)

1. Theise ND NO, Park YN, Nakanuma Y,. Combined hepatocellular carcinoma-cholangiocarcinoma. In:, Bosman FT GF, Hruban RH, Theise ND, ed. WHO classification of tumours of the digestive system, 4th edition. Lyon: IARC Press; 2010. p 225-227.
2. Allen RA, Lisa JR,. Combined liver cell and bile duct carcinoma. Am J Pathol 1949; 25: 647-655.
3. Jarnagin WR, Weber S, Tickoo SK, et al. Combined hepatocellular and cholangiocarcinoma: demographic, clinical, and prognostic factors. Cancer 2002; 94: 2040-2046. (Pubitemid 34270058)
4. Koh KC, Lee H, Choi MS, et al. Clinicopathologic features and prognosis of combined hepatocellular cholangiocarcinoma. Am J Surg 2005; 189: 120-125. (Pubitemid 40215518)
5. Primary liver cancer in Japan,. Clinicopathologic features and results of surgical treatment. Liver Cancer Study Group of Japan. Ann Surg 1990; 211: 277-287.
6. Taguchi J, Nakashima O, Tanaka M, Hisaka T, Takazawa T, Kojiro M,. A clinicopathological study on combined hepatocellular and cholangiocarcinoma. J Gastroenterol Hepatol 1996; 11: 758-764. (Pubitemid 26252907)
7. Chantajitr S, Wilasrusmee C, Lertsitichai P, Phromsopha N,. Combined hepatocellular and cholangiocarcinoma: clinical features and prognostic study in a Thai population. J Hepatobiliary Pancreat Surg 2006; 13: 537-542. (Pubitemid 46766710)
8. Goodman ZD, Ishak KG, Langloss JM, Sesterhenn IA, Rabin L,. Combined hepatocellular-cholangiocarcinoma. A histologic and immunohistochemical study. Cancer 1985; 55: 124-135. (Pubitemid 15198209)
9. Lee WS, Lee KW, Heo JS, et al. Comparison of combined hepatocellular and cholangiocarcinoma with hepatocellular carcinoma and intrahepatic cholangiocarcinoma. Surg Today 2006; 36: 892-897.
10. Haradome H, Grazioli L, Tinti R, et al. Additional value of gadoxetic acid-DTPA-enhanced hepatobiliary phase MR imaging in the diagnosis of early-stage hepatocellular carcinoma: comparison with dynamic triple-phase multidetector CT imaging. J Magn Reson Imaging 2011; 34: 69-78.
11. Chou CT, Chen YL, Su WW, Wu HK, Chen RC,. Characterization of cirrhotic nodules with gadoxetic acid-enhanced magnetic resonance imaging: the efficacy of hepatocyte-phase imaging. J Magn Reson Imaging 2010; 32: 895-902.
12. Bartolozzi C, Crocetti L, Lencioni R, Cioni D, Della Pina C, Campani D,. Biliary and reticuloendothelial impairment in hepatocarcinogenesis: the diagnostic role of tissue-specific MR contrast media. Eur Radiol 2007; 17: 2519-2530.
13. Hammerstingl R, Huppertz A, Breuer J, et al. Diagnostic efficacy of gadoxetic acid (Primovist)-enhanced MRI and spiral CT for a therapeutic strategy: comparison with intraoperative and histopathologic findings in focal liver lesions. Eur Radiol 2008; 18: 457-467. (Pubitemid 351248177)
14. Jung G, Breuer J, Poll LW, et al. Imaging characteristics of hepatocellular carcinoma using the hepatobiliary contrast agent Gd-EOB-DTPA. Acta Radiol 2006; 47: 15-23. (Pubitemid 43177525)
15. Huppertz A, Balzer T, Blakeborough A, et al. Improved detection of focal liver lesions at MR imaging: multicenter comparison of gadoxetic acid-enhanced MR images with intraoperative findings. Radiology 2004; 230: 266-275. (Pubitemid 37549812)
16. Choi BI, Han JK, Shin YM, Baek SY, Han MC,. Peripheral cholangiocarcinoma: comparison of MRI with CT. Abdom Imaging 1995; 20: 357-360.
17. Fan ZM, Yamashita Y, Harada M, et al. Intrahepatic cholangiocarcinoma: spin-echo and contrast-enhanced dynamic MR imaging. AJR Am J Roentgenol 1993; 161: 313-317. (Pubitemid 23224794)
18. Hamrick-Turner J, Abbitt PL, Ros PR,. Intrahepatic cholangiocarcinoma: MR appearance. AJR Am J Roentgenol 1992; 158: 77-79.
19. Maetani Y, Itoh K, Watanabe C, et al. MR imaging of intrahepatic cholangiocarcinoma with pathologic correlation. AJR Am J Roentgenol 2001; 176: 1499-1507. (Pubitemid 32510270)
20. Tani K, Kubota Y, Yamaguchi T, et al. MR imaging of peripheral cholangiocarcinoma. J Comput Assist Tomogr 1991; 15: 975-978.
21. Vilgrain V, Van Beers BE, Flejou JF, et al. Intrahepatic cholangiocarcinoma: MRI and pathologic correlation in 14 patients. J Comput Assist Tomogr 1997; 21: 59-65. (Pubitemid 27061157)
22. Lim JH,. Cholangiocarcinoma: morphologic classification according to growth pattern and imaging findings. AJR Am J Roentgenol 2003; 181: 819-827. (Pubitemid 37021861)
23. Kim YK, Han YM, Kim CS,. Comparison of diffuse hepatocellular carcinoma and intrahepatic cholangiocarcinoma using sequentially acquired gadolinium-enhanced and Resovist-enhanced MRI. Eur J Radiol 2009; 70: 94-100.
24. Aoki K, Takayasu K, Kawano T, et al. Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features and computed tomographic findings. Hepatology 1993; 18: 1090-1095. (Pubitemid 23320437)
25. Masamichi K,. Combined hepatocellular carcinoma and cholangiocarcinoma. In:, Masamichi K, editor. Pathology of hepatocellular carcinoma, 1st edition. Malden, MA: Blackwell; 2006. p 105-115.
26. Gabata T, Matsui O, Kadoya M, et al. Delayed MR imaging of the liver: correlation of delayed enhancement of hepatic tumors and pathologic appearance. Abdom Imaging 1998; 23: 309-313. (Pubitemid 28213309)
27. Kajiyama K, Maeda T, Takenaka K, Sugimachi K, Tsuneyoshi M,. The significance of stromal desmoplasia in intrahepatic cholangiocarcinoma: a special reference of 'scirrhous-type' and 'nonscirrhous-type' growth. Am J Surg Pathol 1999; 23: 892-902. (Pubitemid 29360106)
28. Rimola J, Forner A, Reig M, et al. Cholangiocarcinoma in cirrhosis: absence of contrast washout in delayed phases by magnetic resonance imaging avoids misdiagnosis of hepatocellular carcinoma. Hepatology 2009; 50: 791-798.